આજે બ્રિટાનિયા, ગોદરેજ સીપી, હીરો મોટોકોર્પ, IGL, LIC હાઉસિંગ ફાઇનાન્સ, REC, સન ફાર્મા, ટાટા સ્ટીલ અને થોમસ કૂક જાહેર કરશે પરીણામ

અમદાવાદ, 1 નવેમ્બરઃ

Q2FY24 EARNING CALENDAR 01.11.2023: AJMERA, AMBUJACEM, APTECHT, ARVSMART, AWL, BRITANNIA, CERA, DIVGIITTS, FINOPB, GAEL, GMDCLTD, GODREJCP, GREENPANEL, GREENPOWER, HEROMOTOCO, IGL, INDIACEM, JINDRILL, JKTYRE, JUBLINGREA, KEC, LICHSGFIN, MAHSEAMLES, MASFIN, NETWEB, NILKAMAL, PDSL, PLAZACABLE, RECLTD, RELAXO, RTNPOWER, SAREGAMA, SUNPHARMA, SYRMA, TATASTEEL, THOMASCOOK, TRITURBINE, TVTODAY, UNICHEMLAB

AWL

Revenue expected at Rs 12,417 crore versus Rs 14,150 crore

EBITDA expected to be seen at Rs 207 crore versus Rs 253 crore

EBITDA margin expected to be seen at 1.67% versus 1.79%

Net profit expected to be seen at Rs 61 Lakh versus of Rs 48 crore

BRITANNIA

Revenue expected at Rs 4646 crore versus Rs 4338 crore

EBITDA expected to be seen at Rs 794 crore versus Rs 712 crore

EBITDA margin expected to be seen at 17.1% versus 16.4%

Net profit expected to be seen at Rs 535 crore versus of Rs 493 crore

GODREJCP

Revenue expected at Rs 3570 crore versus Rs 3392 crore

EBITDA expected to be seen at Rs 684 crore versus Rs 542 crore

EBITDA margin expected to be seen at 19.16% versus 15.98%

Net profit expected to be seen at Rs 454 crore versus of Rs 381 crore

HEROMOTOCO

Revenue expected at Rs 9369 crore versus Rs 9075 crore

EBITDA expected to be seen at Rs 1329 crore versus Rs 1038 crore

EBITDA margin expected to be seen at 14.1% versus 11.4%

Net profit expected to be seen at Rs 977 crore versus of Rs 716 crore

IGL

Revenue expected at Rs 3435 crore versus Rs 3554 crore

EBITDA expected to be seen at Rs 659 crore versus Rs 527 crore

EBITDA margin expected to be seen at 19.18% versus 14.84%

Net profit expected to be seen at Rs 476 crore versus of Rs 426 crore

KEC

Revenue expected at Rs 4584 crore versus Rs 4064 crore

EBITDA expected to be seen at Rs 287 crore versus Rs 178 crore

EBITDA margin expected to be seen at 6.26% versus 4.37%

Net profit expected to be seen at Rs 84 crore versus of Rs 55 crore

LICHSGFIN

Revenue expected at Rs 2141 crore versus Rs 1205 crore

EBIT expected to be seen at Rs 1816 crore versus Rs 939 crore

EBIT margin expected to be seen at 84.82% versus 77.90%

Net profit expected to be seen at Rs 1138 crore versus of Rs 312 crore

RECLTD

Revenue expected at Rs 4200 crore versus Rs 9938 crore

EBIT expected to be seen at Rs 4038 crore versus Rs 4101 crore

EBIT margin expected to be seen at 96.0% versus 41.26%

Net profit expected to be seen at Rs 2993 crore versus of Rs 2728 crore

RELAXO

Revenue expected at Rs 753 crore versus Rs 669 crore

EBITDA expected to be seen at Rs 109 crore versus Rs 59 crore

EBITDA margin expected to be seen at 14.48% versus 8.87%

Net profit expected to be seen at Rs 55 crore versus of Rs 22 crore

SUNPHARMA

Revenue expected at Rs 12,006 crore versus Rs 10,952 crore

EBITDA expected to be seen at Rs 3147 crore versus Rs 2957 crore

EBITDA margin expected to be seen at 26.2% versus 27.0%

Net profit expected to be seen at Rs 2187 crore versus of Rs 2262 crore

TATASTEEL

Revenue expected at Rs 57,920 crore versus Rs 59,878 crore

EBITDA expected to be seen at Rs 4869 crore versus Rs 6060 crore

EBITDA margin expected to be seen at 8.40% versus 10.1%

Net profit expected to be seen at Rs 279 crore versus of Rs 2625 crore

Q2FY24 EARNING CALENDAR 02.11.2023: ADANIENT, ADANIPOWER, APTUS, ASAHIINDIA, BALKRISHNA, BOMDYEING, CHEMPLASTS, CHOLAFIN, CLEAN, CONCOR, DABUR, DATAMATICS, DEEPAKFERT, EIHAHOTELS, GODREJPROP, GUJGAS, HERANBA, HIKAL, IEX, IFBIND, INFIBEAM, IRFC, JKLAKSHMI, KIRLOSENG, KPIL, KSB, KTKBANK, LALPATHLAB, LINC, MINDACORP, MOREPENLAB, NOCIL, PSPPROJECT, RATNAMANI, RELIGARE, SAPPHIRE, SFL, SOLARINDS, SUZLON, TATAMOTORS, TATAMTRDVR, TATVA, TI, XCHANGING

(Disclaimer: The information provided here is investment advice only. Investing in the markets is subject to risks and please consult your advisor before investing.)

(સ્પષ્ટતા: અત્રેથી આપવામાં આવતી તમામ પ્રકારની માહિતી કોઇપણ પ્રકારે રોકાણ, ટ્રેડીંગ માટેની સલાહ નથી. બજારોમાં રોકાણ જોખમોને આધીન છે અને રોકાણ કરતા પહેલા કૃપા કરીને તમારા સલાહકારની સલાહ લો.)